Skip to main content
. 2020 Jan 24;9(2):100. doi: 10.3390/antiox9020100

Figure 2.

Figure 2

Percentages of (A) total viable sperm (SYBR14+/PI-), (B) viable sperm with high membrane lipid disorder (M540+/YO-PRO-1-), (C) viable apoptotic-like sperm (AnnexinV+/PI-) and (D) viable acrosome membrane-intact sperm (PNA-FITC-/PI-) of semen samples treated with ethacrynic acid (EA), a glutathione S-transferases (GSTs) inhibitor, and the control group, assessed at different evaluation times during liquid storage at 17 °C (0, 24, 48, and 72 h). Different letters (a, b) indicate significant differences (p < 0.05) between treatments within storage time.